-
Evaluating complex interventions
Tsiachristas A. and Rutten-van Mölken M., (2017), Handbook Integrated Care
-
Economic evaluation of factorial randomised controlled trials: Challenges, methods and recommendations
Dakin HA. and Gray A., (2017), Statistics in Medicine
-
Using genomic information to guide ibrutinib treatment decisions in chronic lymphocytic leukaemia: a cost-effectiveness analysis
Buchanan J. et al, (2017), PharmacoEconomics
-
Including health economic analysis in pilot studies: lessons learned from a cost-utility analysis within the PROSPECTIV pilot study
Burns RM. et al, (2017), Global and Regional Health Technology Assessment
-
Costs of fragility hip fractures globally: a systematic review and meta-regression analysis
Williamson S. et al, (2017), Osteoporosis International
-
Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach.
Ramos-Goñi JM. et al, (2017), Med Care, 55, e51 - e58
-
Should the Republic of Ireland introduce a national prostate-specific antigen testing programme for the secondary detection of prostate cancer? Results from a population-based cost-effectiveness analysis
Burns RM. et al, (2017), In: European Journal of Cancer February 2017Volume 72, Supplement 1, Page S117
-
Process mining routinely collected electronic health records to define real-life clinical pathways during chemotherapy.
Baker K. et al, (2017), Int J Med Inform, 103, 32 - 41
-
Core outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations.
Webster L. et al, (2017), PLoS One, 12, e0179521 - e0179521